Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man-Reference-Cited by-同舟云学术

Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man

Published:1998-06 Issue:3 Volume:76 Page:317-325
ISSN:0304-3959
Container-title:Pain
language:en
Short-container-title:

Author:

Bickel A,Dorfs S,Schmelz M,Forster C,Uhl W,Handwerker O H.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Anesthesiology and Pain Medicine,Clinical Neurology,Neurology

Reference21 articles.

1. Nociceptor discharges and sensations due to prolonged noxious mechanical stimulation - a paradox. Hum.;Adriaensen;Neurobiol,1984

2. Perineurial defect and peripheral opioid analgesia in inflammation. J.;Antonijevic;Neurosci,1995

3. Pharmacological prophile of the novel, peripherally-selective -opioid agonist, EMD 61753. Br. J.;Barber;Pharmacol,1994

4. Nervous outflow from the cats foot during noxious radiant heat stimulation.;Beck;Brain Res,1974

5. Calcitonin gene-related peptide, substance P and nitric oxide are involved in cutaneous inflammation following ultraviolet irradiation. Eur. J.;Benrath;Pharmacol,1995

Cited by 89 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effects of systemic oxytocin administration on ultraviolet B-induced nociceptive hypersensitivity and tactile hyposensitivity in mice;Molecular Pain;2024-01

2. Development of Multifunctional and Orally Active Cyclic Peptide Agonists of Opioid/Neuropeptide FF Receptors that Produce Potent, Long-Lasting, and Peripherally Restricted Antinociception with Diminished Side Effects;Journal of Medicinal Chemistry;2021-09-01

3. Human surrogate models of central sensitization: A critical review and practical guide;European Journal of Pain;2021-05-08

4. Strategies for DevelopingκOpioid Receptor Agonists for the Treatment of Pain with Fewer Side Effects;Journal of Pharmacology and Experimental Therapeutics;2020-09-10

5. GABAergic modulation of secondary hyperalgesia: A randomized controlled 4‐way crossover trial with the α2‐subunit preferring GABA positive allosteric modulator, N ‐desmethyl‐clobazam in healthy volunteers;European Journal of Pain;2020-04